Kalbe Farma, PT Registered Shares RP 10

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

62.50%

Market Cap

-

P/E Ratio

14.97

Dividend Yield

1.66 %

Earnings per Share

0.00 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.027 G0 Units
PRICE DETERMINATION TIME07/24/2026 / 01:50:58 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.030.026
PREV. DAY'S PRICE0.027 (07/23)
CHANGE DAY BEFORE
+0.00
0.00 %
52 WEEK HIGH / LOW0.073 (08/27)0.023 (06/08)

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.000.000.000.000.00
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
1.93 %2.65 %1.66 %--
DIVIDEND GROWTH IN %
-22.71 %11.60 %-48.75 %--
PRICE - EARNINGS RATIO
26.9219.3814.979.058.32
PRICE - BOOK RATIO
3.482.742.34--
PRICE - SALES RATIO
2.451.931.55--
PRICE - CASH FLOW RATIO
25.2512.8615.90--
Further Key Figures

Master Data

WKN
A1J5U9
ISIN
ID1000125107
SYMBOL
LCLA
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Kalbe Farma
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
3.85 %
-6.90 %
-28.00 %
-51.79 %
-62.50 %
-75.89 %
-59.09 %
-43.75 %
HIGH0.030.030.050.060.070.100.180.06
LOW0.030.030.020.020.020.020.020.02

Dividende

pro Aktie

Company profile

PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical division offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores. The Consumer Health division includes over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals division sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistic division maintains distribution of the company's and third party principal's products across Indonesia; and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.